-
Lifton, Clausi, Cashin and Putnam on how the time for scandium is now
The Technology Metals Show hosts Jack Lifton and Peter Clausi talk to Peter Cashin, President and CEO of…
-
Co-founder Thomas Smeenk on the benefits of Hemostemix autologous stem cell therapy
In a recent InvestorIntel interview, Peter Clausi speaks with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc.…
-
Adding dynaCERT to Your CleanTech Portfolio
After spending 16 years and over $60 million to develop its CleanTech technology, dynaCERT Inc. (TSX: DYA |…
